Company Filing History:
3 out of 4 
3 out of 1,187 
Years Active: 2020-2023
Title: Dean Stamos: Innovator in Cereblon Modulation
Introduction
Dean Stamos is a prominent inventor based in San Diego, CA. He has made significant contributions to the field of pharmacology, particularly in the modulation of cereblon neosubstrates. With a total of 3 patents to his name, Stamos is recognized for his innovative approaches to drug development.
Latest Patents
Stamos's latest patents focus on "Cereblon modulators and uses thereof." These patents disclose compositions and methods for modulating cereblon neosubstrates. A small molecule modulator of Formula (I*), or a pharmaceutically acceptable salt or solvate thereof, can be utilized to modulate cereblon neosubstrates effectively.
Career Highlights
Throughout his career, Dean Stamos has worked with notable organizations such as Vividion Therapeutics, Inc. and The Scripps Research Institute. His work in these institutions has allowed him to advance his research and contribute to the scientific community.
Collaborations
Stamos has collaborated with esteemed colleagues, including Benjamin F. Cravatt and Matthew Patricelli. These partnerships have further enriched his research endeavors and have led to significant advancements in the field.
Conclusion
Dean Stamos is a key figure in the innovation of cereblon modulation, with a focus on developing new therapeutic methods. His contributions to the field are noteworthy and continue to impact pharmacological research.